Studies on interleukin 2 receptor expression and IL-2 production by murine T cell lymphomas. by Diamantstein, T. et al.
Br. J. Cancer (1985), 51, 23-30
Studies on interleukin 2 receptor expression and IL-2
production by murine T cell lymphomas
T. Diamantstein', H. Osawal, L. Graf2 & V. Schirrmacher2
lImmunology Research Unit, Klinikum Steglitz, Freie Universitdt Berlin, 1000 Berlin 45, 2lnstitutfiir
Immunologie und Genetik, Deutsches Krebsforschungszentrum, 6900 Heidelberg, FRG
Summary In order to study the possible role of the T-lymphocyte growth factor, Interleukin 2 (IL-2), and/or
of the IL-2 receptor in the autonomous growth of leukaemic cells, 15 mouse leukaemic cell lines of various
aetiology were analyzed for (i) IL-2 receptor expression and (ii) for the capacity to secrete IL-2. Several but
not all of the cell lines tested were IL-2 receptor positive. The cells constitutively expressing IL-2 receptors at
their surface could not be stimulated to secrete IL-2. Cell producing and secreting IL-2 did not express
detectable amounts of IL-2 receptors at their surface. It has been demonstrated that proliferation of the
leukaemic cells was independent of exogenous IL-2. The monoclonal anti-IL-2 receptor antibody AMT-13
inhibited IL-2 dependent proliferation of activated normal T-lymphocytes but failed to inhibit the growth of
IL-2 receptor expressing leukaemic cells. The results argue against the autocrine stimulation hypothesis but do
not exclude the possibility of involvement of functionally altered IL-2 receptors on autonomous cell growth.
For many, if not all cells, the initial trigger for
proliferation appears to be the interaction of
growth factors with the cell surface growth factor
receptor. Activation of the growth factor receptor
leads in turn to yet undefined cytoplasmic signalling
systems.
Resting T lymphocytes are long living cells in the
Go phase of the cell cycle. They only enter pro-
liferative cycles under antigenic stimulation in the
presence of a T cell growth factor, interleukin 2
(IL-2). Receptors for IL-2 are not detectable on the
surface of resting T cells. Expression of IL-2
receptors is the consequence of interaction of
antigen presenting cells with the antigen receptor.
As shown recently, IL-2 receptor expression is a
transient event and repeated restimulation by
lectins (Cantrell & Smith, 1983; Dimantstain &
Osawa, 1984) or the antigen (Reske-Kunz et al.,
1984) is required for continuous IL-2 receptor
expression and consequently for long term cell
growth.
In contrast to activated normal T-cells, adult T
leukaemic cells (ATL cells) constitutively express
IL-2 receptors (Hattori et al., 1981; Yodoi et al.,
1983, Gallo et al., 1983). It seemed plausible to us
to ask whether the constitutive expression of the
IL-2 receptor on leukaemic cells may be associated
with the autonomous growth of the tumour cells.
Recently we reported about the production and
characterization of a monoclonal antibody (AMT-
13) recognizing the IL-2 receptor present on the
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surface of activated murine T cells (Osawa &
Diamantstein, 1984a,b). Theaimsofthepresentreport
were (i) to search for IL-2 receptor expression on
murine T leukaemic cells of various aetiology and
(ii) to search for arguments for or against the
autocrine stimulation hypothesis (Gallo & Wong-
Staal, 1982).
Materials and methods
Cell lines
The aetiology and origin of most of the tumour
lines used has been described (Bosslet et al., 1979).
The cell lines were grown in RPMI-1640 medium
supplemented with 10% foetal calf serum and
antibiotics as described (Bosslet et al., 1979). Their
characteristics relevant to the presented studies are
indicated in Table I.
Preparation ofcells
T lymphoblasts were obtained by culturing
2 x 106ml-I splenocytes with 3pgml-1
concanavalin A (ConA; Pharmacia Fine Chemicals,
Uppsala, Sweden) in culture medium for 3 days.
The cells were harvested and, to inactivate ConA,
were treated with 20mgml-1 of a-methyl-
mannoside as described previously (Reimann &
Diamantstein, 1980). Metabolically blocked T-
lymphoblasts were prepared by incubating T-
lymphoblasts (106cellsml-1) with 50pgml-1 of
mitomycin C at 37°C for 1 h as described
previously (Reimann & Diamantstein, 1980).
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Cell cultures
Cells (105ml-1) were cultured in a final volume of
0.2ml in microtiter plates (Greiner, Niirtingen,
FRG) in culture medium consisting of RPMI-1640
medium, supplemented with 5% FCS, 2 x 10-3M
glutamine, streptomycin (50 pgml-1), penicillin
(lOOIUml-1) and 5x1O-5M 2-mercaptoethanol.
Cultures were incubated at 37°C in 5% CO2 in air.
Four hours before termination of the culture
period, each well was pulsed with 10 p1 of [3H]-
thymidine ([3H]-TdR, 0.1 pCi, specific activity
2CimM-1, Radiochemical Centre, Amersham
Buchler, Braunschweig, FRG). Uptake of [3H]-TdR
was determined as described (Diamantstein et al.,
1981). Each value represents the mean of counts
per minute (cpm) detected in triplicate cultures.
Standard error of mean was < 10%. In several
experiments, metabolically blocked T-lymphoblasts
(106cells ml-1) or AMT-13 antibody in ascites form
was added to the cultures. Appropriate concen-
trations of a control ascites fluid (Y3 ascites fluid)
had no effect on the cell cultures.
Preparation ofsemipurified IL-2
IL-2 was prepared from the 48h supernatants of
rat spleen cells cultured with ConA by ammonium
sulfate precipitation and Sephadex G-100 gel fil-
tration exactly as described by Schreier and Tees
(Schreier & Tees, 1981). This semipurified IL-2 was
used throughout the experiments.
Standard assayfor IL-2 activity
IL-2 activity was determined by IL-2 concentration-
dependent proliferation of murine T lymphoblasts.
The murine T lymphoblasts (2 x 104 cells) were
incubated in 0.2ml of culture medium in the
presence of serial twofold dilutions of a standard
IL-2 preparation and the experimental sample. The
cells were cultured for 72h and [3H]-TdR uptake by
the cells determined. The dilution of the standard
IL-2 preparation yielding 50% of the maximal [3H]-
thymidine uptake was defined as 1 U of IL-2.
IL-2 absorption assay
Cells (5 x 107) were washed twice with PBS, and
resuspended in 0.2ml of IL-2 (100Uml- 1). The
suspensions were incubated for 1.5h at 37°C. The
cells were spun down, and the supernatants were
assayed for remaining IL-2 activity as described
above. The results were expressed as percentages of
IL-2 absorbed by the respective cells.
Fluorescence analysis
For staining, 2 x 106 cells of various origin
suspended in 0. ml of staining buffer (culture
medium containing 0.1% NaN3) were incubated for
30min at 4°C with 0.1 ml of culture supernatant
derived from the clone AMT-13. Controls were
incubated with culture medium or supernatants
derived from Y3 myeloma cells. The cells were
washed with staining buffer and stained, if not
otherwise stated, with an excess of FITC-
conjugated (Fab)2 fragment of sheep anti-rat Ig
(E.Y., San Meteo, CA). The cells were washed,
resuspended in 0.1ml of staining buffer, and fixed
with 0.7% paraformaldehyde. To detect cell
surface-associated antigens recognized by AMT-13
McAb, the cells were subjected to flow
cytofluorometry (FACS, Becton-Dickinson Type
400).
Binding of125I labelled second antibody to AMT-13
McAb binding cells
This assay was performed in PBS containing 0.5%
bovine serum albumin and 10mMNaN3. Cells
(0.5 x 106) were admixed with 5 x 106 sheep red
blood cells (glutaraldehyde-stabilized, Sigma) in
1.5ml medium in order to facilitate subsequent
washings. The mixture was incubated for 30min at
4°C. The cells were pelleted and resuspended in
1OOp1 AMT-13 supernatant (dilution 1:3) or 10O,l
medium as a control. After an incubation period of
30min at 4°C, the cells were washed with 1 ml of
medium and resuspended in 100ll 1251-labelled
sheep anti-rat Ig, (Fab')2 fragment, diluted 1:10
(10pCI g-1, 100pCIml-1, Amersham Buchler,
Braunschweig, FRG). Sixty minutes later, the cells
were washed twice and the radioactivity associated
with the cell pellet was determined in a Packard
Gamma spectrometer. Each cell population was
tested in triplicate.
Attempts to induce IL-2 production
Balb/c splenocytes or various lymphoma cell lines
(2 x 106cellsml-1) were incubated with lOngml-1
of phorbolmyristate acetate (PMA, Sigma
Miinchen, FRG) or 3pgml - of ConA or with a
combination of PMA and ConA for 2 days
(primary cultures). In order to defect IL-2 activity
0.02ml of the respective culture supernatants
containing 20mgml-1 of a-methylmannoside were
added to 0.2ml of T-lymphoblasts (105 cellsml-1)
and at day 3 of the culture period [3H]-thymidine
uptake by the cells detected (secondary cultures).
Results
Detection ofIL-2 receptors on murine lymphoma cell
lines
In order to search for IL-2 receptor bearing lym-
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Table I Staining of murine lymphoma cell lines for IL-2 receptor expression
using monoclonal antibody AMT-13 and a cytofluoro-graphic analysis
Tumour line % positive cellsb
Designation Typea Strain neg. control AMT-13
RI. A spont. thymoma C58 1.3 (365) 2.5 (265)C
El-4 chem. lymph. (T) C57B1/6 16.6 (263) 14.8 (235) SL-2 spont. lymph. (T) DBA/2 4.1 (245) 14.2 (254)0
FBL-3 virus lymph. (T) C57B1/6 2.7 (198) 6.9 (238)0
BW5147TGR spont. lymph. (T) AKR 0.6 (308) 2.6 (308)C
S-B1O. RIII spont. lymph. 310. RIII 10.9 (218) 23.9 (241)0
GIL-IV virus lymph. C57B1/6 6.8 (209) 7.2 (218)
LSTRA virus lymph. Balb/c 11.1 (195) 15.2 (191)
RBL-5 virus lymph. (T) C57B1/6 4.4 (151) 4.2 (211)
ULMC chem. lymph. Balb/c 6.9 (224) 6.3 (210)
RLo-1 rad. lymph. (T) Balb/c 9.0 (206) 57.0 (261)
1.7 (174) 95.2 (434)C Eb chem. lymph. (T) DBA/2 14.8 (235) 81.3 (601)
8.9 (220) 92.9 (414)C ESb met. variant of Eb DBA/2 21.4 (231) 63.2 (326)
9.6 (215) 48.0 (237)0
ESb-M adh. variant of ESb DBA/2 14.4 (182) 52.0 (209)0
E24 hybridoma of ESb DBA/2 10.0 (223) 37.8 (255)C
aspont. =spontaneous; chem. =chemically induced; virus =virus induced; rad.
=radiation induced; met. =metastatic; adh. =adherent; S-B10. RIII is a sponta-
neous lymphoma from our own colony of BlO. RIII mice; the origin of the other
tumour lines used is described elsewhere.
bThe histograms consisted of 1000 channels, with channels 80-1000 counted as
positive. Values in brackets are mean fluorescent intensity.
cResults of a test with rabbit anti rat Ig-FITC instead of(Fab')2 - sheep anti rat
Ig-FITC as second antibody. Negative control was second antibody alone.
lines were incubated with the monoclonal rat anti
IL-2 receptor antibody AMT-13 (Osawa &
Diamanstein, 1984a) and subsequently with FITC-
conjugated anti-rat Ig. The results of the
cytofluorometic analysis summarized in Table I
show that some but not all lymphoma lines bind
the McAb AMT-13 specifically.
Three out of the lymphoma cell lines were
selected for a more detailed analysis: Eb-cells
binding high level of AMT-13 antibody, Esb-cells
binding a small but significant amount of AMT-13
antibody and EL-4 cells that failed to bind
detectable amounts of AMT-13 antibody. The
capacity of these cell lines to bind the antibody
AMT-13 was compared to that of normal T-
lymphoblasts by using a more sensitive indirect
radioactive binding assay. Various numbers of the
respective cells were incubated with a saturating
amount of the McAb AMT-13 and with 1251-
labelled (Fab')2-fragments of anti-rat Ig as a
second antibody. The results summarized in Figure
1 demonstrate that the Eb-cells and T-lymphoblast
bind comparable amount of the McAb AMT-13.
ESb cells bind the antibody AMT-13, only
marginally as compared to Eb cells while El-4 cells
were completely negative.
Binding of the McAb AMT-13 by activated T-
cells has been shown to be paralleled by their
capacity to absorb IL-2 activity (Osawa &
Diamantstein, 1984a). As shown in Figure 2 cells
such as T-lymphoblasts and Eb-cells carrying high
numbers of binding sites for the McAb AMT-13
more effectively absorbed IL-2 activity than ESb-
cells carrying small numbers of binding sites for
this antibody. EL-4 cells and thymocytes did not
absorb detectable amounts of IL-2 activity.
Attempts to induce IL-2production by IL-2 receptor
positive and IL-2 receptor negative T-lymphoma lines
We asked whether IL-2 receptor expressing lymphoma cell lines are capable of producing IL-2.
Eb-cells and ESb-cells that bind the McAb AMT-
13 and EL-4 cells known to produce IL-2 but
shown to lack binding sites for the McAb AMT-13
were cultured for 48h with various doses of PMA26 T. DIAMANTSTEIN et al.
Eb (in dose range of 1-100ngPMA per
T-blast 2 xl06cellsml-1) or with various doses of ConA
(l-lO,ug ConA per 2xlO6cellsml-P) or a
combination of PMA and ConA (primary cultures).
Cell free supernatants derived from primary
cultures containing a-methylmannoside
(20mgml-1) were then tested for IL-2 activity. The
results of a typical experiment using optimum
stimulatory doses of PMA and ConA are
summerized in Figure 3. Stimulation of EL-4 cells
for IL-2 production was achieved by incubating the
cells with 1Ong PMA but not with ConA.
Combination of lOng PMA and 3pg ConA gave
optimum stimulation. Neither of the PMA or
ConA doses added separately or in combination to
Eb or ESb cells induced detectable amounts of IL-
2.
Esb
104 -
EL-4
0 50 150
Cells/assay
500 x 103
Figure 1 Binding of [1251]-labelled second antibody to
cells preincubated with the McAb AMT-13. The
indicated numbers of the different cells were incubated
with hybridoma supernatant derived from the clone
AMT-13 and subsequently with [1251]-labelled F(ab')2
fragment of sheep anti rat Ig. In triplicates, the
radioactivity associated with the cells was determined.
S.e.m. was less than 5%.
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Lack of'inihibition hY metabolicallY' inactivated
T-li'inphohlasts of proliferation of IL-2 receptor
positive or negative T-lvmnphotna cells
It is possible that cells producing IL-2 consume IL-
2 and therefore IL-2 activity is not detectable in the
supernatants of such cell cultures. One of the
possibilities to test whether IL-2 produced in a
system is driving the proliferation of the cells is to
deplete the culture of available IL-2. As reported
previously (Gunther et ail., 1982), metabolically
inactivated T-lymphoblasts expressing high
amounts of IL-2 receptor, when added to such
cultures, inhibit specifically the IL-2 dependent
proliferation by competing for the available IL-2.
In order to test whether proliferation of T-
lymphoma cells carrying IL-2 receptor, e.g. Eb or
ESb cells, is IL-2 driven the cells were cultured in
the presence of an excess of mitomycin blocked
syngeneic (DBA/2) T-lymphoblasts. As positive
controls normal (DBA/2) T-lymphoblasts were
cultured with IL-2 in the presence and absence of
metabolically blocked syngeneic T-lymphoblasts.
As an additional control IL-2 receptor negative EL-
4 lymphoma cells were cultured with syngeneic
(C57B1) mitomycin inactivated T-lymphoblasts. The
cells (105ml 1) were cultured for 2 days and [3H]-
thymidine uptake by the cells determined. The
results of a typical experiment summarized in
Figure 4, show that proliferation of normal T-
lymphoblasts in response to IL-2 can be inhibited
by the cocultured metabolically inactivated T-
lymphoblasts. The inhibition of the response was
specific, since addition of an excess of IL-2 to the
cultures reversed the inhibitory activity of the
metabolically blocked T-lymphoblasts. However,
the proliferation of the lymphoma cells could not
be inhibited by metabolically inactivated T-
lymphoblasts.
Lack ofinhibition of'proliferation of T-[rn7phonia
cells hv the monoclonal ainti-IL-2 receptor antihody
AMT-13
We previously reported that the McAB AMT-13
can inhibit IL-2 dependent proliferation of IL-2
receptor bearing cells (Osawa & Diamantstein,
1984a). We therefore wanted to investigate the
proliferation of IL-2 receptor bearing T-lymphoma
cells can be inhibited by this antibody too. As a
positive control T-lymphoblasts were cultured in
the presence of a saturating amount of IL-2. The
results of a typical experiment are summarised in
Figure 5. They show that the antibody AMT-13
inhibits the IL-2 driven proliferation of T-lympho-
blasts but does not inhibit the proliferation of
either IL-2 receptor positive (Eb and ESb) or IL-2
receptor negative (EL-4) lymphoma cells.
a)
0
E
0
Eb Esb EL-4 T-blast
Figure 4 Lack of inhibition by mitomycin-inactivated
syngeneic T-lyphoblasts of proliferation of the lym-
phoma cells. Eb, ESb or EL-4 cells (4 x 104) were
cultured alone (open bars) or in the presence (black
bars) of 106 mitomycin-blocked syngeneic T-lympho-
blasts. 4 x 104DBA/2 T-lymphoblasts were cultured
with 2U of IL-2 (a) or with 2U of IL-2 and 106
syngeneic mitomycin-blocked T-lymphoblasts (b) or
as b, but in additional presence of 20 U of IL-2 (c). At
day 3 of the culture period [3H]-thymidine uptake by
the cells was determined. Each value represenits the
mean of cpm culture detected in triplicates. S.c.m.
was <Iboo.
Discussion
To the best of our knowledge this is the first
description of IL-2 receptor expression on murine T
cell tumours. Most previous studies on T cell
growth factor receptors on tumours were concerned
with human adult T cell leukaemias and lympho-
mas (ATL), which have been associated with a
novel retrovirus HTLV. It had been hypothesized
that the continuous proliferation of ATL cells may
result from continuous stimulation of their own IL-
2 receptors by the elaboration of IL-2 (Gallo et al.,
1983). In the ATL lines, however, no evidence for
constitutive IL-2 production could be found (Yodoi
et al., 1983; Arya et al., 1984). Nevertheless, a
possible functional role of IL-2 receptors on ATL
cells is not excluded. Based on the observation
that the putative physiologic regulation mechanism of
IL-2 reccptor expression, down regulation of the
receptor, is lacking in ATL cells (Tsudo et al.,
1983) it was hypothesized that the "constitutive"28 T. DIAMANTSTEIN et al.
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Figure 5 Lack of inhibition of tumour cell pro-
liferation by the McAb AMT-13. Eb (0), ESb (O) or
EL-4 (0) cells (2 x 104) were cultured with various
dilutions of ascites fluid containing the McAb AMT-
13 for 2 days. DBA/2 T-lymphoblasts (2 x 104) (U)
were cultured with 2U of IL-2 with the corresponding
dilutions of the ascites fluid. Each value represents the
mean of [3H]-thymidine uptake by the cells detected in
triplicate cultures.
expression of the growth factor receptor could be
responsible for the unrestricted proliferation of
ATL cells.
Since the IL-2 receptor expression by ATL cells
appears to be virus-induced it seemed to us of
interest to investigate receptor expression by T cell
tumours of different aethiology in order to find out
whether the continuous proliferation of T cell
tumours may be generally or occasionally linked
with constitutive growth factor receptor expression.
Some of the investigated tumour lines were found
to express IL-2 receptor when tested with the help
of the McAb AMT-13 and flow cytofluorographic
analysis. The majority of the tumour lines tested,
however, did not bind the anti-receptor antibody to
any detectable degree. These tumour lines included
chemically induced (ULMC, EL-4), virus induced
(GIL-IV, RBL-5, FBL-3) and "spontaneous" ones
(RL.A, S1-2, BW 5147). Evidence for consitutive
cell surface expression of IL-2 receptors was,
however, provided for the line L5178YE (Eb), a
chemically induced T cell lymphoma of DBA/2
origin. This line was comparable to ConA activated
normal T blasts with regard to AMT-13 Ab
binding, and IL-2 absorbing activity. The
spontaneous high metastatic variant of this tumour,
ESb, which we described in much detail previously
(Schirrmacher et al., 1979; Bosslet & Schirrmacher,
1981; Dzarlieva et al., 1982), also expressed IL-2
receptors, but to a lower extent. This finding was
surprising in so far as a previous finger printing
analysis of plasma membrane proteins had shown
more similarities of ConA blasts with ESb than
with Eb type cells (Altevogt & Schirrmacher, in
press).
In contrast to the report of Farrar et al. (1982)
the chemically induced T cell leukaemia line EL-4
was clearly negative for IL-2 receptor expression
when tested by AMT-13 binding and by IL-2
absorption. The continuous growth of the AMT-13
st antigen negative lines, including this tumour, thus
appear to be independent of IL-2 receptor
expression. The possibility cannot be excluded,
however, that the negative tumours may have IL-2
receptors inside of the cells or may express other
growth factor receptors which could mediate trigger
signals for continuous proliferation. Eb tumour
cells appeared to express IL-2 receptors in a similar
order of magnitude as ConA blasts. In the presence
of anti-receptor monoclonal antibodies, the IL-2
driven proliferation of activated normal T cells was
inhibited in a dose-dependent manner while the Eb
tumour cells were not affected. This difference
could be explained either (i) by the difference in IL-
2 dependency of the two cell types and thus of
competition of IL-2 binding sites in one case but
not the others or (ii) by a difference in receptor
modulation (e.g. down-regulation) by anti-receptor
antibody as reported for ATL cells (Tsudo et al.,
1983).
Next we investigated the ability of the tumour
lines Eb, ESb and EL-4 to produce IL-2, either
constitutively or upon stimulation with the tumour
promotor PMA, the mitogen ConA or both. We
found that the ability to produce IL-2 was not
associated with the expression of the IL-2 receptor.
Thus, the two lines Eb and ESb which expressed
the receptor did not produce IL-2 to any detectable
amount under any of the test conditions, while EL-
4 cells, which did not express the receptor, could be
stimulated to IL-2 production.
While these results gave no hint to a possible role
of an autocrine stimulatory mechanism via IL-2
and IL-2 receptor in these T cell lymphomas, we
still had to exclude the possibility that IL-2 might
be produced only locally and become absorbed
immediately by the tumour cell IL-2 receptors. This
was excluded by the negative outcome of a
competition assay with admixed metabolically
blocked T lymphoblasts.
It is of course still possible that IL-2 receptors on
-f ,,, 1,
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Eb or ESb cells could interact with IL-2 from
"inside" the cells, by an intramembranous IL-2/IL-
2 receptor interaction, as suggested by Gallo et al.
(1982). But such a mechanism has not been
demonstrated for any cell type.
It is also possible that in Eb cells as well as in
ATL cells the mechanisms which lead to altered
and tumorous growth have nothing to do with the
IL-2/IL-2 receptor system. The tumour lines could
be stimulated by other growth factors or they could
produce factors which may mimic the functional
activity of a regulatory component along the
intracellular signalling system. Experimental data
have recently been summarized which support the
notion that growth factor independence and
autonomous growth of transformed cells might be
due to a constitutive expression of any of the
controlling elements along the normal mitogenic
pathway - the growth factor itself, the membrane
receptor that serves as a transducer of the
extracellular signal, or the intracellular signal
system which ultimately leads to the initiation of
DNA synthesis and cell division. The constitutively
expressed factors, which function as transforming
proteins in the malignant cell, may be encoded by
oncogenes or their expression may be under the
control of oncogenes (Heldin et al., 1984). Thus
there are obviously several ways by which a
transformed cell becomes independent of normal
growth control. Which of these may be operative in
the respective tumour lines studied remains to be
elucidated.
This work was supported in part by the Deutsche
Forschungsgemeinschaft (Di-152-83).
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